Koala Health, a digital pet pharmacy company, announced the completion of a $20 million Series B funding round led by Valspring Capital, marking a significant milestone in the company's mission to modernize pet medication delivery and management.
The Boston-based company plans to use the funding to accelerate development of its mobile-first digital platform and enhance service offerings for both pet owners and veterinary professionals. Koala Health's platform currently serves more than 80 million pet parents across all 50 states through its online storefront at Koala.health.
Addressing Veterinary Care Challenges
"Veterinary clinics are busier than ever, and many pet owners are facing long wait times for appointments," said Gavin Cotter, CEO and founder of Koala Health. "At Koala, we make it easy to stay on top of pet medications by working directly with both pet parents and their veterinarians—saving time and providing greater peace of mind when it comes to a pet's health."
The platform addresses a critical gap in veterinary care by providing a fully integrated prescription solution to over 25,000 independent veterinary clinics nationwide. This system eliminates the burden of in-house medication storage and fulfillment for veterinary practices, allowing them to focus on patient care rather than inventory management.
Technology-Driven Solution
Koala Health's platform features one-click prescription capabilities that simplify medication management for veterinarians while ensuring pets receive necessary medications without delays. The company positions itself as a bridge between veterinarians and pet parents, creating what it describes as a more efficient ecosystem for pet healthcare.
"Koala Health is redefining the pet prescription experience by building a seamless bridge between veterinarians and pet parents," said Yumin Choi of Valspring Capital. "By partnering directly with clinics and making it easier for pet owners to manage medications, Koala is creating a smarter, more efficient ecosystem that benefits everyone involved. It's a modern solution to a long-overdue problem in veterinary care."
Market Position and Growth
The company describes itself as the leading digital pet pharmacy, offering a best-in-class pharmacy solution available wherever pet care occurs. The platform's reach extends to both direct-to-consumer services through its online storefront and business-to-business solutions for veterinary clinics.
Valspring Capital, the lead investor in this funding round, is a Boston-based growth equity firm established in 2022 by the former healthcare investment team of Bain Capital Ventures. The firm focuses on growth-stage companies in the healthcare industry, particularly in information technology, technology-enabled services, and services sectors.
